Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study

被引：0
|
作者：
Lushan Xiao
Yanxia Liao
Jiaren Wang
Qimei Li
Hongbo Zhu
Chang Hong
Ruining Li
Jingzhe He
Hao Cui
Hanzhi Dong
Lin Zeng
Li Liu
机构：
[1] Southern Medical University,Big Data Center, Nanfang Hospital
[2] Southern Medical University,Department of Infectious Diseases, Nanfang Hospital
[3] University of South China,Department of Medical Oncology, The First Affiliated Hospital, Hengyang Medical School
[4] Jiangxi Clinical Research Center for Cancer,Department of Medical Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Immune checkpoint inhibitors; Elderly; Primary liver cancer; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2299 / 2308
页数：9
相关论文
共 50 条
  • [1] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Xiao, Lushan
    Liao, Yanxia
    Wang, Jiaren
    Li, Qimei
    Zhu, Hongbo
    Hong, Chang
    Li, Ruining
    He, Jingzhe
    Cui, Hao
    Dong, Hanzhi
    Zeng, Lin
    Liu, Li
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2299 - 2308
  • [2] Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China
    Yang, Yang
    Tan, Lijie
    Hu, Jian
    Li, Yin
    Mao, Yousheng
    Tian, Ziqiang
    Zhang, Baihua
    Ma, Jianqun
    Li, Hecheng
    Chen, Chun
    Chen, Keneng
    Han, Yongtao
    Chen, Longqi
    Liu, Junfeng
    Yu, Bentong
    Yu, Zhentao
    Li, Zhigang
    [J]. DISEASES OF THE ESOPHAGUS, 2022, 35 (11)
  • [3] Real-world cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a retrospective controlled cohort study
    Zhang, Chuan
    Chen, Zhulu
    Mo, Chunhua
    Gao, Diansha
    Zhu, Yuxi
    Qin, Shu
    Zuo, Zhong
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6074 - +
  • [4] Real-World Efficacy and Safety of Off-Label Use of Immune Checkpoint Inhibitors (ICI) in Cancer: A Retrospective Cohort Study in Qatar
    Abaza, S.
    Nasser, S.
    Abuyounis, M.
    Nounou, A.
    Rasul, K.
    Hamad, A.
    Elazzazy, S.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1300 - 1301
  • [5] Efficacy and safety of immune checkpoint inhibitors in older HCC patients: A real-world study
    Cheng, J.
    Chen, B.
    Lu, Y.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S338 - S338
  • [6] Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
    Gong, Xiaoling
    Zhu, Yahui
    Zhang, Qianning
    Qiu, Xin
    Lu, Changchang
    Tong, Fan
    Wang, Qiaoli
    Kong, Weiwei
    Zhou, Haihui
    Liu, Baorui
    Zhou, Yujie
    Du, Juan
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [7] Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
    Toribio-Garcia, Irene
    Olivares-Hernandez, Alejandro
    Miramontes-Gonzalez, Jose Pablo
    Dominguez, Luis Posado
    Garcia, Ana Martin
    Bachiller, Rocio Eiros
    Figuero-Perez, Luis
    Martinez, Maria Garijo
    Ruiz, Jonnathan Roldan
    Hernandez, Lorena Bellido
    Fonseca-Sanchez, Emilio
    Sanchez, Pedro Luis
    del Barco-Morillo, Edel
    [J]. CANCERS, 2023, 15 (17)
  • [8] SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASES: A NATIONWIDE MULTICENTER RETROSPECTIVE STUDY
    Tison, A.
    Quere, G.
    Misery, L.
    Funck-Brentano, E.
    Danlos, F. -X.
    Bonniaud, B.
    Scalbert, C.
    Lesimple, T.
    Martinez, S.
    Marcq, M.
    Chouaid, C.
    Dubos, C.
    Brunet-Possenti, F.
    Stavris, C.
    Chiche, L. Y.
    Cornec, D.
    Kostine, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 147 - 147
  • [9] Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study)
    Orsini, Diego
    Caldarola, Giacomo
    Dattola, Annunziata
    Campione, Elena
    Bernardini, Nicoletta
    Frascione, Pasquale
    De Simone, Clara
    Richetta, Antonio G.
    Galluzzo, Marco
    Skroza, Nevena
    Assorgi, Chiara
    Amore, Emanuele
    Falco, Gennaro M.
    Shumak, Ruslana Gaeta
    Artosi, Fabio
    Maretti, Giulia
    Potenza, Concetta
    Bianchi, Luca
    Pellacani, Giovanni
    Peris, Ketty
    Bonifati, Claudio
    Graceffa, Dario
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [10] Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study
    Tison, Alice
    Quere, Gilles
    Misery, Laurent
    Funck-Brentano, Elisa
    Danlos, Francois-Xavier
    Routier, Emilie
    Robert, Caroline
    Loriot, Yohann
    Lambotte, Olivier
    Bonniaud, Bertille
    Scalbert, Camille
    Maanaoui, Sarah
    Lesimple, Thierry
    Martinez, Stephanie
    Marcq, Marie
    Chouaid, Christos
    Dubos, Catherine
    Brunet-Possenti, Florence
    Stavris, Chloe
    Chiche, Laurent
    Beneton, Nathalie
    Mansard, Sandrine
    Guisier, Florian
    Doubre, Helene
    Skowron, Francois
    Aubin, Francois
    Zehou, Ouidad
    Roge, Christophe
    Lambert, Mickael
    Pham-Ledard, Anne
    Beylot-Barry, Marie
    Veillon, Remi
    Kramkimel, Nora
    Giacchero, Damien
    De Quatrebarbes, Julie
    Michel, Catherine
    Auliac, Jean-Bernard
    Gonzales, Gilles
    Decroisette, Chantal
    Le Garff, Gwenaelle
    Carpiuc, Ioana
    Vallerand, Herve
    Nowak, Emmanuel
    Cornec, Divi
    Kostine, Marie
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71 (12) : 2100 - 2111
12345